Abstract: A system for pharmaceutical compounding, includes a workspace surface having an outer boundary, a display embedded within the workspace surface, the display having a plurality of edges that are impermeably sealed between the workspace surface, a computing device providing a user interface to the display, an enclosed housing extending from the outer boundary of the workspace surface and having an opening for a user to access the workspace surface, and an air filtration system providing a negative pressure airflow within the enclosed housing. The display is flush with the workspace surface. The system may further include a gravimetric scale positioned on the workspace surface, a cabinet attached to a first side of the enclosed housing, a label printer coupled to the computing device and positioned within the cabinet, and/or a code scanner coupled to the computing device and positioned within the cabinet.

Abstract: The present invention relates to compositions comprising antibodies or fragments thereof that immunospecifically bind to one or more antigens of a flavivirus, particularly of West Nile Virus (WNV), and methods for preventing, treating or ameliorating symptoms associated with a flavivirus, particularly of West Nile Virus (WNV), infection utilizing said compositions. In particular, the present invention relates to methods for preventing, treating or ameliorating symptoms associated with WNV infection, said methods comprising administering to a human subject an effective amount of one or more antibodies or fragments thereof that immunospecifically bind to a WNV antigen. The present invention also relates to detectable or diagnostic compositions comprising antibodies or fragments thereof that immunospecifically bind to a WNV antigen and methods for detecting or diagnosing WNV infection utilizing said compositions.